CD58 and myeloid sarcoma: CD58 is widely expressed in hematolymphoid cells, which is relevant to the MS disease phenotype and makes it ideal for splicing quantitative trait loci (sQTL) analysis as a large number of well-characterized, EBV-transformed lymphoblastoid cell lines (LCLs) expressing CD58 are readily accessible.